Salute ME - Search Results

1

In vitro effects of the tyrosine kinase inhibitor, masitinib mesylate, on canine hemangiosarcoma cell lines.

Lyles SE, Milner RJ, Kow K, Salute ME. Lyles SE, et al. Among authors: salute me. Vet Comp Oncol. 2012 Sep;10(3):223-35. doi: 10.1111/j.1476-5829.2012.00335.x. Epub 2012 May 18. Vet Comp Oncol. 2012. PMID: 22594682

2

Radiosensitivity and capacity for radiation-induced sublethal damage repair of canine transitional cell carcinoma (TCC) cell lines.

Parfitt SL, Milner RJ, Salute ME, Hintenlang DE, Farese JP, Bacon NJ, Bova FJ, Rajon DA, Lurie DM. Parfitt SL, et al. Among authors: salute me. Vet Comp Oncol. 2011 Sep;9(3):232-40. doi: 10.1111/j.1476-5829.2010.00258.x. Epub 2011 Jun 27. Vet Comp Oncol. 2011. PMID: 21848626

3

In vitro effects of Yunnan Baiyao on canine hemangiosarcoma cell lines.

Wirth KA, Kow K, Salute ME, Bacon NJ, Milner RJ. Wirth KA, et al. Among authors: salute me. Vet Comp Oncol. 2016 Sep;14(3):281-94. doi: 10.1111/vco.12100. Epub 2014 Jun 29. Vet Comp Oncol. 2016. PMID: 24976212

4

Intrinsic radiosensitivity and repair of sublethal radiation-induced damage in canine osteosarcoma cell lines.

Fitzpatrick CL, Farese JP, Milner RJ, Salute ME, Rajon DA, Morris CG, Bova FJ, Lurie DM, Siemann DW. Fitzpatrick CL, et al. Among authors: salute me. Am J Vet Res. 2008 Sep;69(9):1197-202. doi: 10.2460/ajvr.69.9.1197. Am J Vet Res. 2008. PMID: 18764694 Free article.

5

Apoptotic effects of the tyrosine kinase inhibitor, masitinib mesylate, on canine osteosarcoma cells.

Fahey CE, Milner RJ, Kow K, Bacon NJ, Salute ME. Fahey CE, et al. Among authors: salute me. Anticancer Drugs. 2013 Jun;24(5):519-26. doi: 10.1097/CAD.0b013e32836002ba. Anticancer Drugs. 2013. PMID: 23466652

6

Canine osteosarcoma checkpoint expression correlates with metastasis and T-cell infiltrate.

Cascio MJ, Whitley EM, Sahay B, Cortes-Hinojosa G, Chang LJ, Cowart J, Salute M, Sayour E, Dark M, Sandoval Z, Mitchell DA, Milner RJ. Cascio MJ, et al. Vet Immunol Immunopathol. 2021 Feb;232:110169. doi: 10.1016/j.vetimm.2020.110169. Epub 2020 Dec 15. Vet Immunol Immunopathol. 2021. PMID: 33387703

7

Novel application of single-cell next-generation sequencing for determination of intratumoral heterogeneity of canine osteosarcoma cell lines.

Ayers J, Milner RJ, Cortés-Hinojosa G, Riva A, Bechtel S, Sahay B, Cascio M, Lejeune A, Shiomitsu K, Souza C, Hernandez O, Salute M. Ayers J, et al. J Vet Diagn Invest. 2021 Mar;33(2):261-278. doi: 10.1177/1040638720985242. Epub 2021 Jan 15. J Vet Diagn Invest. 2021. PMID: 33446089 Free PMC article.

8

Effect of bevacizumab on angiogenesis and growth of canine osteosarcoma cells xenografted in athymic mice.

Scharf VF, Farese JP, Coomer AR, Milner RJ, Taylor DP, Salute ME, Chang MN, Neal D, Siemann DW. Scharf VF, et al. Among authors: salute me. Am J Vet Res. 2013 May;74(5):771-8. doi: 10.2460/ajvr.74.5.771. Am J Vet Res. 2013. PMID: 23627391 Free article.

9

Effects of aurothiomalate treatment on canine osteosarcoma in a murine xenograft model.

Scharf VF, Farese JP, Siemann DW, Abbott JR, Kiupel M, Salute ME, Milner RJ. Scharf VF, et al. Among authors: salute me. Anticancer Drugs. 2014 Mar;25(3):332-9. doi: 10.1097/CAD.0000000000000061. Anticancer Drugs. 2014. PMID: 24304691

10

The immune response to disialoganglioside GD3 vaccination in normal dogs: a melanoma surface antigen vaccine.

Milner RJ, Salute M, Crawford C, Abbot JR, Farese J. Milner RJ, et al. Vet Immunol Immunopathol. 2006 Dec 15;114(3-4):273-84. doi: 10.1016/j.vetimm.2006.08.012. Epub 2006 Oct 5. Vet Immunol Immunopathol. 2006. PMID: 17027091 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters